基于重组的VP2-2b全长ELISA用于评估对犬类帕尔沃病毒-2的免疫保护:表达,发展和验证
Ezgi Salmanli1, Taner Karaoglu2
1Department of Virology, Faculty of Veterinary Medicine, Ankara University, Ankara, Turkey; METU MEMS Research and Application Center, Ankara, Turkey.
Analytical biochemistry
|February 5, 2026
概括
使用重组CPV-2b蛋白的新ELISA测试可以准确检测犬类帕尔沃病毒-2抗体. 这种可靠的方法通过克服传统测试的局限性,有助于疫苗接种时间.
科学领域:
- 兽医免疫学 兽医免疫学
- 狗的传染病 狗的传染病
- 诊断检测试验 诊断检测试验
背景情况:
- 狗类帕维病毒-2 (CPV-2) 对狗的健康构成重大威胁.
- 孕产妇的抗体可能会干扰CPV-2疫苗的疗效.
- 传统的诊断方法,如血液凝结抑制 (HI) 测试是有限的.
研究的目的:
- 开发和验证一种用于检测CPV-2抗体的新型间接ELISA.
- 为传统的诊断方法提供可靠和具有成本效益的替代方案.
- 帮助确定最佳的CPV-2疫苗接种时间.
主要方法:
- 开发一种使用全长,重组VP2-2b蛋白表达在大肠杆菌中的间接ELISA.
- 优化抗原涂层度和血清稀释.
- 对ELISA与HI测试的临床验证.
主要成果:
- 开发的ELISA显示了对CPV-2抗体检测的高灵敏度和特异性.
- 确定了最佳的测定条件 (7.5微克抗原,1:300血清稀释),高SNR为5.6.
- 对边界标位定义了一个灰色区域,指导重新测试以准确的疫苗接种时间.
结论:
- 新型ELISA系统是传统CPV-2血清检测的可靠和经济的替代方案.
- 这种测定有助于就CPV-2疫苗接种策略做出明智的决定.
- 在实地应用中,ELISA克服了HI测试的局限性.
相关概念视频
Reliability and Validity
14.1K
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
14.1K
Piaget's Stage 2 of Cognitive Development
942
The preoperational stage, the second of Jean Piaget's four stages of cognitive development, spans approximately ages 2 to 7 and is characterized by the emergence of symbolic thinking. During this stage, children use language, images, and symbols to represent objects and concepts, enabling them to engage in imaginative and pretend play. This symbolic thinking supports children's ability to perform make-believe actions, such as imagining a broom as a horse or their hand as a phone, blending...
942
In Vitro Drug Release Testing: Overview, Development and Validation
357
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
357
Recombinant DNA
103.3K
Overview
103.3K
Homologous Recombination
63.3K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
63.3K
Viral Recombination
25.2K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.2K


